StockNews.com assumed coverage on shares of USD Partners (NYSE:USDP – Free Report) in a research report report published on Tuesday morning. The brokerage issued a hold rating on the transportation company’s stock.
USD Partners Stock Performance
Shares of NYSE USDP opened at $0.06 on Tuesday. The stock has a market capitalization of $2.03 million, a PE ratio of 0.27 and a beta of 0.74. The stock’s fifty day simple moving average is $0.12 and its two-hundred day simple moving average is $0.15. USD Partners has a 12-month low of $0.02 and a 12-month high of $0.99.
USD Partners (NYSE:USDP – Get Free Report) last issued its quarterly earnings data on Tuesday, May 7th. The transportation company reported ($0.26) EPS for the quarter. The firm had revenue of $9.76 million during the quarter.
About USD Partners
USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks.
Featured Stories
- Five stocks we like better than USD Partners
- Find and Profitably Trade Stocks at 52-Week Lows
- RXO Shares Surge Following New Acquisition Deal
- With Risk Tolerance, One Size Does Not Fit All
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- The 3 Best Fintech Stocks to Buy Now
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for USD Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USD Partners and related companies with MarketBeat.com's FREE daily email newsletter.